Abstracts tagged "metabolic syndrome"

Abstract Number: 1704 • 2015 ACR/ARHP Annual Meeting
Prevalence of Obesity and Metabolic Syndrome in Patients with Axial Spondyloarthritis
Graciela Betancur¹, Maria Celeste Orozco², Emilce Schneeberger², Ana Lizarraga¹, Natalia Zamora², Fernando Andres Sommerfleck³ and Gustavo Citera², ¹Reumatologia, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ²Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ³Rheumatologia, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina
Background/Purpose: Estimate the prevalence of Obesity (O) and Metabolic Syndrome (MS) in AxSpA and evaluate its association with sociodemographic and clinical variables. Methods: We included…
Abstract Number: 1275 • 2014 ACR/ARHP Annual Meeting
Association Between Cardiometabolic Disorders and Hand Osteoarthritis Severity: A Cross-Sectional and Longitudinal Study
Alice Courties¹, Jérémie Sellam¹, Francis Berenbaum¹, Emmanuel Maheu¹, Yoann Barthe², Fabrice Carrat² and Christian Cadet³, ¹AP-HP, Saint-Antoine Hospital, Rheumatology Department and DHU i2B, Paris, France, ²Public Health, Saint-Antoine Hospital, Inserm UMRS_1136, UPMC Univ Paris 06, AP-HP, Paris, France, ³Rheumatology, Private office, Paris, France
Background/Purpose Obesity and metabolic disorders increase the risk of hand osteoarthritis (HOA). This study aimed to determine i) clinical and radiographic features associated with HOA…
Abstract Number: 1090 • 2014 ACR/ARHP Annual Meeting
Association of Objectively Measured Physical Activity and Metabolic Syndrome Among Adults with Osteoarthritis in the United States
Shao-Hsien Liu¹, Charles Eaton^2,3 and Kate Lapane⁴, ¹Clinical and Population Health Research Program, Graduate School of Biomedical Science, University of Massachusetts Medical School, Worcester, MA, ²Departments of Family Medicine and Epidemiology, Warren Alpert Medical School, School of Public Health, Brown University, Providence, RI, ³Center for Primary Care and Prevention, Memorial Hospital of Rhode Island, Providence, RI, ⁴Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA
Background/Purpose: Metabolic syndrome increases the risk of osteoarthritis (OA). The accumulation of components of the metabolic syndrome is associated with a gradual increase in the…
Abstract Number: 2762 • 2013 ACR/ARHP Annual Meeting
Rheumatoid and Psoriatic Arthritis Are Not Associated With Higher Risk Of Incident Diabetes Mellitus
Susan Mathew¹, Xiaoqin Tang², H. Lester Kirchner³, Mary Chester M. Wasko⁴ and Androniki Bili¹, ¹Rheumatology, Geisinger Medical Center, Danville, PA, ²Biostatistics, Geisinger Center for Health Research, Danville, PA, ³Geisinger Center for Health Research, Geisinger Health System, Danville, PA, ⁴West Penn Allegheny Health System, Temple University School of Medicine, Pittsburgh, PA
Background/Purpose: Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are chronic inflammatory conditions that are associated with increased risk of insulin resistance and cardiovascular disease…
Abstract Number: 1683 • 2013 ACR/ARHP Annual Meeting
High Prevalence Of Metabolic Syndrome In Takayasu Arteritis: An Increased Cardiovascular Risk and Lower Adiponectin Serum Levels
Thiago Silva¹, Mauricio Levy-Neto², Rosa M. R. Pereira³ and Eloisa Bonfa⁴, ¹Rheumatology Division, University of São Paulo, São Paulo, Brazil, ²Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil, ³Rheumatology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ⁴Rheumatology Division, Universidade de Sao Paulo, São Paulo, Brazil
Background/Purpose: The prevalence of Metabolic Syndrome (MetS) tends to be high among rheumatic patients, and cardiovascular disease is the leading cause of death in these…
Abstract Number: 1401 • 2013 ACR/ARHP Annual Meeting
Reduced Oral Glucose Tolerance Is Associated With a Lower Risk Of Rheumatoid Arthritis
Carl Turesson¹, Ulf Bergström², Mitra Pikwer², Jan-Åke Nilsson² and Lennart Jacobsson¹, ¹Section of Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, ²Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden
Background/Purpose: Studies have demonstrated a negative association between high body mass index (BMI) and development of rheumatoid arthritis (RA) in men, and a neutral or…
Abstract Number: 618 • 2013 ACR/ARHP Annual Meeting
Active Renal Disease Is Associated With The Presence Of The Metabolic Syndrome (MetS) In Peruvian Patients With Systemic Lupus Erythematosus (SLE)
Manuel F. Ugarte-Gil^1,2, Rocio V. Gamboa-Cardenas³, Mariela Medina-Chinchon¹, Francisco Zevallos-Miranda¹, Karim E. Diaz-Deza³, J. Mariano Cucho-Venegas¹, Zoila Rodriguez-Bellido^1,4, Jose L. Alfaro-Lozano¹, Risto A. Perich-Campos^1,4, Erika Noriega³, Hugo Torrealva¹ and Cesar A. Pastor-Asurza^1,4, ¹Rheumatology, Hospital Guillermo Almenara, EsSalud, Lima, Peru, ²Universidad Cientifica del Sur, Lima, Peru, ³Rheumatology, Hospital Almenara, Lima, Peru, ⁴Universidad Nacional Mayor de San Marcos, Lima, Peru
Background/Purpose: The MetS prevalence is increased in SLE patients, in particular in those of Hispanic origin and it is associated with a higher risk for…
Abstract Number: 278 • 2012 ACR/ARHP Annual Meeting
Evaluating Cardiovascular Risk Factors of Impaired Glucose Tolerance, Diabetes Mellitus, and Metabolic Syndrome in a Primarily Latino Population with Pediatric Rheumatic Diseases Associated with Vasculitis
Sara M. Stern¹, Jamie Wood², Katherine AB Marzan¹, Andreas Reiff¹, Bracha Shaham¹ and Diane Brown¹, ¹Division of Rheumatology, Children's Hospital Los Angeles, Los Angeles, CA, ²Division of Endocrinology, Children's Hospital Los Angeles, Los Angeles, CA
Background/Purpose: Pediatric (PED) systemic rheumatic diseases associated with vasculitis (DAV) such as Systemic Lupus Erythematosus (SLE), Mixed Connective Tissue Disease (MCTD) and the various systemic…
Abstract Number: 210 • 2012 ACR/ARHP Annual Meeting
An Analysis of Metabolic Syndrome in Adult Dermatomyositis with a Focus On Cardiovascular Disease
Mariana T. Moraes¹, Fernando H.C. Souza², Thiago B. M. Barros¹ and Samuel K. Shinjo¹, ¹Rheumatology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ²Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
Background/Purpose: Metabolic syndrome (MetS) is a cluster of metabolic abnormalities associated with increased cardiovascular risk. MetS has been systematically evaluated in all systemic autoimmune rheumatic…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].